Torrent Pharma shares gain on JB Chemicals stake increase, zero USFDA observation

Torrent Pharma

Torrent Pharma share price gained in the early trade on January 27 after the company further increased its stake in JB Chemicals and received zero observations from the USFDA.

At 09:28am, Torrent Pharmaceuticals was quoting at Rs 3,939.40, up Rs 12.45, or 0.32 percent, on the BSE.

On January 23, 2026, the company has acquired 37,82,566 equity shares of JB Chemicals & Pharmaceuticals, representing 2.36% of the equity share capital on a fully diluted basis, from certain employees of JB Chemicals.

After the said acquisition, the company holds an aggregate of 7,82,65,402 equity shares, representing 48.75% of the equity share capital of JB Chemicals on a fully diluted basis.

Earlier on January 21, the company has completed the acquisition promoter stake of 7,44,81,519 equity shares of JB Chemicals, representing 46.39% on a fully diluted basis, from Tau Investment Holdings Pte. and classified as a promoter of the company. And also acquired 1,317 equity shares under the open offer.

Catch all the market action on our live blog

In another development, the USFDA inspected Torrent Pharma’s Dahej manufacturing facility from January 19 to 23 and concluded the inspection with zero observations.

In the previous trading session, the stock closed at Rs 3,926.95, down Rs 97.05, or 2.41 percent. The share touched a 52-week high of Rs 4,124.95 on January 20, 2026, and a 52-week low of Rs 2,891.45 on March 3, 2025. Currently, the stock is trading 4.8 percent below its 52-week high and 35.81 percent above its 52-week low. The company’s market capitalisation stands at Rs 1,32,905.83 crore.

The company’s share price has risen 20 percent over the past one year.